IBDEI082 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3625,1,2,0)
 ;;=2^459.89
 ;;^UTILITY(U,$J,358.3,3625,1,5,0)
 ;;=5^Ecchymosis Multiple
 ;;^UTILITY(U,$J,358.3,3625,2)
 ;;=^87910
 ;;^UTILITY(U,$J,358.3,3626,0)
 ;;=686.8^^31^319^2
 ;;^UTILITY(U,$J,358.3,3626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3626,1,2,0)
 ;;=2^686.8
 ;;^UTILITY(U,$J,358.3,3626,1,5,0)
 ;;=5^Ecthyma
 ;;^UTILITY(U,$J,358.3,3626,2)
 ;;=^88097
 ;;^UTILITY(U,$J,358.3,3627,0)
 ;;=039.0^^31^319^6
 ;;^UTILITY(U,$J,358.3,3627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3627,1,2,0)
 ;;=2^039.0
 ;;^UTILITY(U,$J,358.3,3627,1,5,0)
 ;;=5^Erythrasma
 ;;^UTILITY(U,$J,358.3,3627,2)
 ;;=^29822
 ;;^UTILITY(U,$J,358.3,3628,0)
 ;;=035.^^31^319^5
 ;;^UTILITY(U,$J,358.3,3628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3628,1,2,0)
 ;;=2^035.
 ;;^UTILITY(U,$J,358.3,3628,1,5,0)
 ;;=5^Erysipelas
 ;;^UTILITY(U,$J,358.3,3628,2)
 ;;=^42012
 ;;^UTILITY(U,$J,358.3,3629,0)
 ;;=057.9^^31^319^8
 ;;^UTILITY(U,$J,358.3,3629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3629,1,2,0)
 ;;=2^057.9
 ;;^UTILITY(U,$J,358.3,3629,1,5,0)
 ;;=5^Exanthem(Viral)
 ;;^UTILITY(U,$J,358.3,3629,2)
 ;;=^266599
 ;;^UTILITY(U,$J,358.3,3630,0)
 ;;=686.9^^31^319^3
 ;;^UTILITY(U,$J,358.3,3630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3630,1,2,0)
 ;;=2^686.9
 ;;^UTILITY(U,$J,358.3,3630,1,5,0)
 ;;=5^Ecthyma gangrenosum
 ;;^UTILITY(U,$J,358.3,3630,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,3631,0)
 ;;=757.39^^31^319^4
 ;;^UTILITY(U,$J,358.3,3631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3631,1,2,0)
 ;;=2^757.39
 ;;^UTILITY(U,$J,358.3,3631,1,5,0)
 ;;=5^Epidermolysis bullosa acquisita
 ;;^UTILITY(U,$J,358.3,3631,2)
 ;;=^87938
 ;;^UTILITY(U,$J,358.3,3632,0)
 ;;=695.9^^31^319^7
 ;;^UTILITY(U,$J,358.3,3632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3632,1,2,0)
 ;;=2^695.9
 ;;^UTILITY(U,$J,358.3,3632,1,5,0)
 ;;=5^Erythroderma, exfoliative
 ;;^UTILITY(U,$J,358.3,3632,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,3633,0)
 ;;=709.09^^31^320^3
 ;;^UTILITY(U,$J,358.3,3633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3633,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,3633,1,5,0)
 ;;=5^Freckles
 ;;^UTILITY(U,$J,358.3,3633,2)
 ;;=Freckles^303313
 ;;^UTILITY(U,$J,358.3,3634,0)
 ;;=709.4^^31^320^2
 ;;^UTILITY(U,$J,358.3,3634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3634,1,2,0)
 ;;=2^709.4
 ;;^UTILITY(U,$J,358.3,3634,1,5,0)
 ;;=5^Foreign Body Reaction/Granuloma
 ;;^UTILITY(U,$J,358.3,3634,2)
 ;;=Foreign Body Reaction/Granuloma^271943
 ;;^UTILITY(U,$J,358.3,3635,0)
 ;;=698.4^^31^320^1
 ;;^UTILITY(U,$J,358.3,3635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3635,1,2,0)
 ;;=2^698.4
 ;;^UTILITY(U,$J,358.3,3635,1,5,0)
 ;;=5^Factitial Dermatitis
 ;;^UTILITY(U,$J,358.3,3635,2)
 ;;=^186786
 ;;^UTILITY(U,$J,358.3,3636,0)
 ;;=228.01^^31^321^1
 ;;^UTILITY(U,$J,358.3,3636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3636,1,2,0)
 ;;=2^228.01
 ;;^UTILITY(U,$J,358.3,3636,1,5,0)
 ;;=5^Hemangioma Skin
 ;;^UTILITY(U,$J,358.3,3636,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,3637,0)
 ;;=705.83^^31^321^2
 ;;^UTILITY(U,$J,358.3,3637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3637,1,2,0)
 ;;=2^705.83
 ;;^UTILITY(U,$J,358.3,3637,1,5,0)
 ;;=5^Hidradentitis Suppuritiva
 ;;^UTILITY(U,$J,358.3,3637,2)
 ;;=^184621
 ;;^UTILITY(U,$J,358.3,3638,0)
 ;;=704.1^^31^321^3
 ;;^UTILITY(U,$J,358.3,3638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3638,1,2,0)
 ;;=2^704.1
 ;;^UTILITY(U,$J,358.3,3638,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,3638,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,3639,0)
 ;;=780.8^^31^321^7
 ;;^UTILITY(U,$J,358.3,3639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3639,1,2,0)
 ;;=2^780.8
